Novo CEO says pills could capture 50% of weight-loss market by 2030 ↧

Novo CEO says pills could capture 50% of weight-loss market by 2030 ↧ ↧ Novo CEO says pills could capture 50% of weight-loss market by 2030 Weight-loss pills could capture as much as ​half of the global obesity drug market by 2030, Novo Nordisk's chief ‌executive told Reuters on Tuesday, as the Danish drugmaker positions itself for a shift away from weekly injections.